OBJECTIVE: Thoracic endovascular aortic repair for chronic type B aortic dissection with associated descending thoracic aneurysm remains controversial. Concerns include potential ischemic complications due to branch vessel origin from the chronic false lumen and continued retrograde false lumen/aneurysm sac pressurization via fenestrations distal to implanted endografts. The present study examines midterm results with thoracic endovascular aortic repair for chronic (>2 weeks) type B aortic dissection with associated aneurysm to better understand the potential role of thoracic endovascular aortic repair for this condition. METHODS: Between March 2005 and December 2009, 51 thoracic endovascular aortic repair procedures were performed at a single institution for management of chronic type B dissection. The indication for thoracic endovascular aortic repair was aneurysm in all cases. A subset of 7 patients (14%) underwent placement of the EndoSure wireless pressure measurement system (CardioMEMS, Inc, Atlanta, Ga) in the false lumen adjacent to the primary tear for monitoring aneurysm sac/false lumen pulse pressure after thoracic endovascular aortic repair. RESULTS: Mean patient age was 57±12 years (range, 30-82 years); 14 patients (28%) were female. Mean aortic diameter was 6.2±1.4 cm. There were no in-hospital/30-day deaths, strokes, or permanent paraplegia/paresis. There were no complications related to compromise of downstream branch vessels arising from the false lumen. Two patients (3.9%) who had preexisting ascending aortic dilation had retrograde acute type A aortic dissection; both were repaired successfully. Median postoperative length of stay was 4 days. Mean follow-up is 27.0±16.5 months (range, 2-60 months). Actuarial overall survival is 77.7% at 60 months with an actuarial aorta-specific survival of 98% over this same time period. Actuarial freedom from reintervention is 77.3% at 60 months. All patients with the EndoSure wireless pressure measurement system exhibited a decrease in aneurysm sac/false lumen pulse pressure indicating a depressurized false lumen. The aneurysm sac/false lumen pulse pressure ratio decreased from 52%±27% at the predischarge measurement to 14%±5% at the latest follow-up reading (P=.029). CONCLUSIONS: Thoracic endovascular aortic repair for chronic type B dissection with associated aneurysm is safe and effective at midterm follow-up. Aneurysm sac/false lumen pulse pressure measurements demonstrate a significant reduction in false lumen endotension, thus ruling out clinically significant persistent retrograde false lumen perfusion and provide proof of concept for a thoracic endovascular aortic repair-based approach. Longer-term follow-up is needed to determine the durability of thoracic endovascular aortic repair for this aortic pathology. Copyright Â
OBJECTIVE: Thoracic endovascular aortic repair for chronic type B aortic dissection with associated descending thoracic aneurysm remains controversial. Concerns include potential ischemic complications due to branch vessel origin from the chronic false lumen and continued retrograde false lumen/aneurysm sac pressurization via fenestrations distal to implanted endografts. The present study examines midterm results with thoracic endovascular aortic repair for chronic (>2 weeks) type B aortic dissection with associated aneurysm to better understand the potential role of thoracic endovascular aortic repair for this condition. METHODS: Between March 2005 and December 2009, 51 thoracic endovascular aortic repair procedures were performed at a single institution for management of chronic type B dissection. The indication for thoracic endovascular aortic repair was aneurysm in all cases. A subset of 7 patients (14%) underwent placement of the EndoSure wireless pressure measurement system (CardioMEMS, Inc, Atlanta, Ga) in the false lumen adjacent to the primary tear for monitoring aneurysm sac/false lumen pulse pressure after thoracic endovascular aortic repair. RESULTS: Mean patient age was 57±12 years (range, 30-82 years); 14 patients (28%) were female. Mean aortic diameter was 6.2±1.4 cm. There were no in-hospital/30-day deaths, strokes, or permanent paraplegia/paresis. There were no complications related to compromise of downstream branch vessels arising from the false lumen. Two patients (3.9%) who had preexisting ascending aortic dilation had retrograde acute type A aortic dissection; both were repaired successfully. Median postoperative length of stay was 4 days. Mean follow-up is 27.0±16.5 months (range, 2-60 months). Actuarial overall survival is 77.7% at 60 months with an actuarial aorta-specific survival of 98% over this same time period. Actuarial freedom from reintervention is 77.3% at 60 months. All patients with the EndoSure wireless pressure measurement system exhibited a decrease in aneurysm sac/false lumen pulse pressure indicating a depressurized false lumen. The aneurysm sac/false lumen pulse pressure ratio decreased from 52%±27% at the predischarge measurement to 14%±5% at the latest follow-up reading (P=.029). CONCLUSIONS: Thoracic endovascular aortic repair for chronic type B dissection with associated aneurysm is safe and effective at midterm follow-up. Aneurysm sac/false lumen pulse pressure measurements demonstrate a significant reduction in false lumen endotension, thus ruling out clinically significant persistent retrograde false lumen perfusion and provide proof of concept for a thoracic endovascular aortic repair-based approach. Longer-term follow-up is needed to determine the durability of thoracic endovascular aortic repair for this aortic pathology. Copyright Â
Authors: Elliot L Chaikof; Jan D Blankensteijn; Peter L Harris; Geoffrey H White; Christopher K Zarins; Victor M Bernhard; Jon S Matsumura; James May; Frank J Veith; Mark F Fillinger; Robert B Rutherford; K Craig Kent Journal: J Vasc Surg Date: 2002-05 Impact factor: 4.268
Authors: G Chad Hughes; Mani A Daneshmand; Madhav Swaminathan; Jeffrey J Nienaber; Errol L Bush; Aatif H Husain; Walter G Wolfe; Richard L McCann Journal: Ann Thorac Surg Date: 2008-11 Impact factor: 4.330
Authors: Stefano Zoli; Christian D Etz; Fabian Roder; Christoph S Mueller; Robert M Brenner; Carol A Bodian; Gabriele Di Luozzo; Randall B Griepp Journal: Ann Thorac Surg Date: 2010-05 Impact factor: 4.330
Authors: Keshava Rajagopal; Joseph G Rogers; Andrew J Lodge; Jeffrey G Gaca; Richard L McCann; Carmelo A Milano; G Chad Hughes Journal: J Heart Lung Transplant Date: 2009-09 Impact factor: 10.247
Authors: Cyrus J Parsa; Mani A Daneshmand; Brian Lima; Keki Balsara; Richard L McCann; G Chad Hughes Journal: Ann Thorac Surg Date: 2010-02 Impact factor: 4.330
Authors: Cyrus J Parsa; Jacob N Schroder; Mani A Daneshmand; Richard L McCann; G Chad Hughes Journal: Ann Thorac Surg Date: 2010-01 Impact factor: 4.330
Authors: Nicholas D Andersen; Jeffrey E Keenan; Asvin M Ganapathi; Jeffrey G Gaca; Richard L McCann; G Chad Hughes Journal: Ann Cardiothorac Surg Date: 2014-05
Authors: Jacob R Gillen; Basil W Schaheen; Kenan W Yount; Kenneth J Cherry; John A Kern; Irving L Kron; Gilbert R Upchurch; Christine L Lau Journal: J Vasc Surg Date: 2014-10-27 Impact factor: 4.268
Authors: Douglas W Jones; Philip P Goodney; Brian W Nolan; Benjamin S Brooke; Mark F Fillinger; Richard J Powell; David H Stone Journal: J Vasc Surg Date: 2014-02-28 Impact factor: 4.268
Authors: Kyriakos Oikonomou; Athanasios Katsargyris; Wolfgang Ritter; Domenico Spinelli; Yuki Seto; Eric L Verhoeven Journal: Ann Cardiothorac Surg Date: 2014-05
Authors: G Chad Hughes; Asvin M Ganapathi; Jeffrey E Keenan; Brian R Englum; Jennifer M Hanna; Matthew A Schechter; Hanghang Wang; Richard L McCann Journal: Ann Thorac Surg Date: 2014-10-01 Impact factor: 4.330